| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO1G MAPT SYNE1 SPTA1 SPTAN1 SPTB APC2 MYO18A PHF6 MAP3K1 PDLIM4 CCDC88C PDLIM3 SIPA1L1 TLN1 MID1 WASF1 EP300 GOLGA2 HTT | 1.58e-05 | 1099 | 125 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYO1G MAPT SYNE1 SPTA1 SPTAN1 SPTB MYO18A PDLIM4 PDLIM3 SIPA1L1 TLN1 WASF1 | 4.80e-05 | 479 | 125 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 5.06e-05 | 12 | 125 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | actin filament binding | 9.27e-05 | 227 | 125 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol 4-kinase activity | 2.31e-04 | 4 | 125 | 2 | GO:0004430 | |
| GeneOntologyMolecularFunction | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor | 5.74e-04 | 6 | 125 | 2 | GO:0004468 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | PLXNA3 WAPL GNL3L MAPT SYNE1 SPTA1 SPTAN1 SPTB APC2 SMC6 HDAC8 ASAP3 SMC4 MAP3K1 PDLIM4 CCDC88C SLIT2 MET OSBP G3BP1 SIPA1L1 MID1 WASF1 CLEC16A EP300 HTT PINK1 | 1.83e-08 | 1342 | 123 | 27 | GO:0033043 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYO1G NAT8B MAPT SPTA1 SPTAN1 SPTB APC2 ASAP3 MAP3K1 KRT73 PDLIM4 CCDC88C SLIT2 MET FAT1 PDLIM3 MID1 WASF1 EP300 GOLGA2 HTT | 2.19e-07 | 957 | 123 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | WAPL GNL3L MAPT SPTA1 SPTAN1 SPTB APC2 MAP3K1 CCDC88C SLIT2 MET MID1 CLEC16A PINK1 | 2.25e-07 | 421 | 123 | 14 | GO:0010639 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | MAPT SPTA1 SPTAN1 SPTB APC2 ASAP3 MAP3K1 PDLIM4 CCDC88C SLIT2 MET MID1 WASF1 EP300 | 3.62e-07 | 438 | 123 | 14 | GO:1902903 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYO1G CDC42BPA SPTA1 SPTAN1 SPTB ASAP3 MYO18A MAP3K1 PDLIM4 CCDC88C SLIT2 MET PTPN1 JUP FAT1 PDLIM3 SIPA1L1 TLN1 WASF1 EP300 | 4.47e-07 | 912 | 123 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO1G CDC42BPA SPTA1 SPTAN1 SPTB ASAP3 MYO18A MAP3K1 PDLIM4 SLIT2 MET PTPN1 FAT1 PDLIM3 SIPA1L1 TLN1 WASF1 EP300 | 1.32e-06 | 803 | 123 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | PLXNA3 MAPT SPTA1 SPTAN1 SPTB APC2 ASAP3 MAP3K1 PDLIM4 CCDC88C SLIT2 MET MID1 WASF1 EP300 | 1.90e-06 | 579 | 123 | 15 | GO:0051493 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 2.28e-06 | 100 | 123 | 7 | GO:0043242 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 2.50e-06 | 194 | 123 | 9 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 2.84e-06 | 197 | 123 | 9 | GO:1902904 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | PLXNA3 WAPL GNL3L MAPT FAT3 SPTA1 SPTAN1 SPTB APC2 MAP3K1 CCDC88C SLIT2 MET MID1 LRP4 CLEC16A EP300 PINK1 | 3.69e-06 | 864 | 123 | 18 | GO:0051129 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.54e-05 | 89 | 123 | 6 | GO:1901880 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | PSD2 OGT CDC42BPA TRIO CCDC88C SLIT2 MET RASAL3 G3BP1 SIPA1L1 LRP4 WASF1 SCAI | 2.01e-05 | 538 | 123 | 13 | GO:0007264 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 2.01e-05 | 192 | 123 | 8 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | GNL3L OGT MAPT SYNE1 SPTA1 SPTAN1 SPTB ASAP3 MAP3K1 PDLIM4 SLIT2 MET SNCAIP G3BP1 SIPA1L1 TLN1 LRP4 EP300 HTT PINK1 | 2.41e-05 | 1189 | 123 | 20 | GO:0044087 |
| GeneOntologyBiologicalProcess | protein depolymerization | 2.53e-05 | 144 | 123 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 2.53e-05 | 144 | 123 | 7 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 3.14e-05 | 333 | 123 | 10 | GO:0051056 | |
| GeneOntologyBiologicalProcess | protein polymerization | 3.23e-05 | 334 | 123 | 10 | GO:0051258 | |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 3.53e-05 | 2 | 123 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | PLXNA3 MAPT SMC4 MAP3K1 PDLIM4 MET OSBP G3BP1 WASF1 CLEC16A EP300 HTT PINK1 | 3.93e-05 | 574 | 123 | 13 | GO:0010638 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 3.96e-05 | 105 | 123 | 6 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 5.39e-05 | 285 | 123 | 9 | GO:0060828 | |
| GeneOntologyBiologicalProcess | actin filament organization | MYO1G SPTA1 SPTAN1 SPTB ASAP3 MAP3K1 PDLIM4 SLIT2 MET FAT1 PDLIM3 WASF1 | 5.39e-05 | 509 | 123 | 12 | GO:0007015 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | PLXNA3 GNL3L MAPT SYNE1 MYO18A SMC4 MAP3K1 PDLIM4 SLIT2 MET OSBP G3BP1 LRP4 WASF1 CLEC16A ALK EP300 PLXNA1 GOLGA2 HTT PINK1 | 5.50e-05 | 1366 | 123 | 21 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 6.27e-05 | 114 | 123 | 6 | GO:0050772 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | SPTA1 SPTAN1 SPTB ASAP3 MAP3K1 PDLIM4 SLIT2 MET JUP WASF1 EP300 | 6.38e-05 | 438 | 123 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 6.75e-05 | 168 | 123 | 7 | GO:0031109 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 7.48e-05 | 231 | 123 | 8 | GO:0032271 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 7.98e-05 | 300 | 123 | 9 | GO:0110053 | |
| GeneOntologyBiologicalProcess | internal protein amino acid acetylation | 8.94e-05 | 15 | 123 | 3 | GO:0006475 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 1.03e-04 | 384 | 123 | 10 | GO:0032956 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 1.05e-04 | 3 | 123 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 1.37e-04 | 252 | 123 | 8 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 1.37e-04 | 252 | 123 | 8 | GO:0006486 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | GNL3L OGT MAPT WBP1L HDAC8 GCG ITGA5 MAP3K1 SLC51B CCNE1 CCDC88C SLIT2 MET PTPN1 OSBP CELSR3 LRP4 EP300 GOLGA2 HTT PINK1 | 1.83e-04 | 1488 | 123 | 21 | GO:0031399 |
| GeneOntologyBiologicalProcess | regulation of hydrogen peroxide-mediated programmed cell death | 1.87e-04 | 19 | 123 | 3 | GO:1901298 | |
| GeneOntologyBiologicalProcess | epithelial cell morphogenesis | 2.07e-04 | 49 | 123 | 4 | GO:0003382 | |
| GeneOntologyBiologicalProcess | glycosylation | 2.19e-04 | 270 | 123 | 8 | GO:0070085 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 2.23e-04 | 344 | 123 | 9 | GO:0060070 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | NAT8B GNL3L OGT CDC42BPA MKNK2 SMC6 SRPK1 GCG ITGA5 MET PTPN1 OSBP LRP4 ALK EP300 PINK1 | 2.28e-04 | 976 | 123 | 16 | GO:0018193 |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | 2.32e-04 | 205 | 123 | 7 | GO:0051495 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | SLC12A6 PLXNA3 OGT MAPT SPTA1 SPTAN1 SPTB MAP3K1 SLIT2 EP300 | 2.39e-04 | 426 | 123 | 10 | GO:0032535 |
| GeneOntologyBiologicalProcess | regulation of protein localization | GNL3L OGT VPS26B MAPT MYO18A GCG SLC51B CCNE1 PTPN1 OSBP JUP CELSR3 LRP4 LZTS2 EP300 HTT PINK1 | 2.49e-04 | 1087 | 123 | 17 | GO:0032880 |
| GeneOntologyBiologicalProcess | cell morphogenesis | PLXNA3 TRIO MAPT SYNE1 FAT3 SPTA1 MAP3K1 CCDC88C SLIT2 MET FAT1 CELSR3 SIPA1L1 LRP4 WASF1 EP300 PLXNA1 GOLGA2 | 2.53e-04 | 1194 | 123 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | retinal metabolic process | 2.54e-04 | 21 | 123 | 3 | GO:0042574 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | APC2 SCEL MAP3K1 CCNE1 CCDC88C JUP CELSR3 G3BP1 TTC21B LRP4 LZTS2 | 2.67e-04 | 516 | 123 | 11 | GO:0016055 |
| GeneOntologyBiologicalProcess | hydrogen peroxide-mediated programmed cell death | 2.93e-04 | 22 | 123 | 3 | GO:0010421 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 2.94e-04 | 357 | 123 | 9 | GO:0009101 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | PLXNA3 MAPT SYNE1 FAT3 SLIT2 MET SIPA1L1 LRP4 ALK EP300 PLXNA1 GOLGA2 | 3.00e-04 | 612 | 123 | 12 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | GNL3L OGT VPS26B MAPT MYO18A GCG SLC51B CCNE1 PTPN1 OSBP JUP CELSR3 TTC21B LRP4 LZTS2 EP300 HTT PINK1 | 3.04e-04 | 1212 | 123 | 18 | GO:0060341 |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | SLC12A6 OGT MAPT HDAC8 GCG ITPR3 SLIT2 MET PTPN1 OSBP JUP FAT1 RDH11 EIF4EBP2 GKAP1 RORA ALK EP300 HTT PINK1 | 3.59e-04 | 1450 | 123 | 20 | GO:1901701 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 3.62e-04 | 291 | 123 | 8 | GO:0032984 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 3.66e-04 | 368 | 123 | 9 | GO:0030111 | |
| GeneOntologyBiologicalProcess | programmed cell death in response to reactive oxygen species | 3.82e-04 | 24 | 123 | 3 | GO:0097468 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 4.75e-04 | 108 | 123 | 5 | GO:0031110 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PLXNA3 TRIO MAPT SYNE1 FAT3 SLIT2 MET CELSR3 SIPA1L1 LRP4 EP300 PLXNA1 GOLGA2 | 5.30e-04 | 748 | 123 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | OGT HDAC8 GCG ITPR3 SLIT2 PTPN1 JUP FAT1 EIF4EBP2 GKAP1 ALK EP300 HTT | 5.57e-04 | 752 | 123 | 13 | GO:1901699 |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 5.61e-04 | 112 | 123 | 5 | GO:0010507 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 6.52e-04 | 66 | 123 | 4 | GO:0007019 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to hypoxia | 6.75e-04 | 29 | 123 | 3 | GO:1900037 | |
| GeneOntologyBiologicalProcess | negative regulation of small GTPase mediated signal transduction | 6.91e-04 | 67 | 123 | 4 | GO:0051058 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | 7.04e-04 | 489 | 123 | 10 | GO:0043254 | |
| GeneOntologyBiologicalProcess | gonadotrophin-releasing hormone neuronal migration to the hypothalamus | 7.26e-04 | 7 | 123 | 2 | GO:0021828 | |
| GeneOntologyBiologicalProcess | hypothalamic tangential migration using cell-axon interactions | 7.26e-04 | 7 | 123 | 2 | GO:0021856 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 8.29e-04 | 591 | 123 | 11 | GO:1903829 | |
| GeneOntologyBiologicalProcess | negative regulation of mitophagy | 9.65e-04 | 8 | 123 | 2 | GO:1901525 | |
| GeneOntologyBiologicalProcess | olfactory nerve development | 9.65e-04 | 8 | 123 | 2 | GO:0021553 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy of mitochondrion | 9.65e-04 | 8 | 123 | 2 | GO:1903147 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial fission | 9.65e-04 | 8 | 123 | 2 | GO:0090258 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | OGT MAPT GCG ITGA5 MAP3K1 CCNE1 CCDC88C SLIT2 MET PTPN1 OSBP CELSR3 LRP4 ALK EP300 HTT PINK1 | 9.76e-04 | 1226 | 123 | 17 | GO:0042325 |
| GeneOntologyBiologicalProcess | actin filament polymerization | 9.84e-04 | 190 | 123 | 6 | GO:0030041 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PLXNA3 TRIO MAPT SYNE1 SLIT2 MET CELSR3 SIPA1L1 LRP4 WASF1 EP300 PLXNA1 GOLGA2 | 1.01e-03 | 802 | 123 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | mitophagy | 1.06e-03 | 75 | 123 | 4 | GO:0000423 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 1.06e-03 | 75 | 123 | 4 | GO:0030837 | |
| GeneOntologyBiologicalProcess | protein N-linked glycosylation | 1.11e-03 | 76 | 123 | 4 | GO:0006487 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 1.11e-03 | 430 | 123 | 9 | GO:0009100 | |
| GeneOntologyBiologicalProcess | positive regulation of supramolecular fiber organization | 1.15e-03 | 196 | 123 | 6 | GO:1902905 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | OGT SPTA1 SPTAN1 SPTB APC2 CCDC88C MID1 CLEC16A GOLGA2 HTT PINK1 | 1.17e-03 | 617 | 123 | 11 | GO:0022411 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PLXNA3 TRIO MAPT SYNE1 SLIT2 MET CELSR3 SIPA1L1 LRP4 WASF1 EP300 PLXNA1 GOLGA2 | 1.22e-03 | 819 | 123 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | hypothalamus cell migration | 1.24e-03 | 9 | 123 | 2 | GO:0021855 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron differentiation | 1.24e-03 | 9 | 123 | 2 | GO:0021886 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron development | 1.24e-03 | 9 | 123 | 2 | GO:0021888 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 1.28e-03 | 36 | 123 | 3 | GO:0034063 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 1.28e-03 | 36 | 123 | 3 | GO:0010560 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.29e-03 | 354 | 123 | 8 | GO:0050769 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PLXNA3 TRIO MAPT SYNE1 SLIT2 MET CELSR3 SIPA1L1 LRP4 WASF1 EP300 PLXNA1 GOLGA2 | 1.32e-03 | 826 | 123 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | SLC12A6 TRIO MAPT SYNE1 PDLIM4 ITPR3 MET SNCAIP SIPA1L1 EIF4EBP2 CADPS2 PDE7B HTT PINK1 | 1.32e-03 | 931 | 123 | 14 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | SLC12A6 TRIO MAPT SYNE1 PDLIM4 ITPR3 MET SNCAIP SIPA1L1 EIF4EBP2 CADPS2 PDE7B HTT PINK1 | 1.32e-03 | 931 | 123 | 14 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | SLC12A6 TRIO MAPT SYNE1 PDLIM4 ITPR3 MET SNCAIP SIPA1L1 EIF4EBP2 CADPS2 PDE7B HTT PINK1 | 1.43e-03 | 939 | 123 | 14 | GO:0099537 |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 1.50e-03 | 38 | 123 | 3 | GO:0007026 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 1.50e-03 | 38 | 123 | 3 | GO:1902473 | |
| GeneOntologyBiologicalProcess | regulation of mitophagy | 1.50e-03 | 38 | 123 | 3 | GO:1901524 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.53e-03 | 207 | 123 | 6 | GO:1990138 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | PLXNA3 MAPT SYNE1 FAT3 SLIT2 MET SIPA1L1 LRP4 ALK EP300 PLXNA1 GOLGA2 HTT | 1.63e-03 | 846 | 123 | 13 | GO:0120035 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO1G CDC42BPA SPTA1 SPTAN1 SPTB APC2 MYO18A PVALEF MAP3K1 PDLIM4 JUP PDLIM3 SIPA1L1 WASF1 | 8.37e-06 | 576 | 124 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | postsynapse | PSD2 OGT TRIO VPS26B MAPT SYNE1 SPTAN1 SPTB APC2 ITGA5 PDLIM4 MET CELSR3 SIPA1L1 EIF4EBP2 LRP4 CADPS2 WASF1 HTT | 8.74e-06 | 1018 | 124 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | spectrin | 1.67e-05 | 9 | 124 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | filamentous actin | 7.45e-05 | 38 | 124 | 4 | GO:0031941 | |
| GeneOntologyCellularComponent | cell leading edge | MYO1G PSD2 CDC42BPA MAPT APC2 ASAP3 ITGA5 PDLIM4 FAT1 TLN1 WASF1 | 1.95e-04 | 500 | 124 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | anchoring junction | USP53 CDC42BPA SPTAN1 ASAP3 ITGA5 PPL PDLIM4 CCDC88C JUP FAT1 PDLIM3 G3BP1 PI4KA TNFSF13B TLN1 WASF1 | 2.16e-04 | 976 | 124 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | intercellular bridge | 2.44e-04 | 94 | 124 | 5 | GO:0045171 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 4.51e-04 | 230 | 124 | 7 | GO:0098562 | |
| GeneOntologyCellularComponent | cell-cell junction | USP53 CDC42BPA SPTAN1 ITGA5 PPL PDLIM4 CCDC88C JUP FAT1 PDLIM3 TLN1 | 7.95e-04 | 591 | 124 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | focal adhesion | 1.09e-03 | 431 | 124 | 9 | GO:0005925 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.13e-03 | 269 | 124 | 7 | GO:0036464 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 1.22e-03 | 9 | 124 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | cell body | PSD2 OGT MAPT ITPR3 SLIT2 MET SNCAIP G3BP1 SIPA1L1 LRP4 ALK GOLGA2 HTT PINK1 | 1.23e-03 | 929 | 124 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | cell-substrate junction | 1.32e-03 | 443 | 124 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | organelle outer membrane | 1.40e-03 | 279 | 124 | 7 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 1.45e-03 | 281 | 124 | 7 | GO:0019867 | |
| GeneOntologyCellularComponent | neuronal ribonucleoprotein granule | 1.52e-03 | 10 | 124 | 2 | GO:0071598 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.60e-03 | 210 | 124 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.64e-03 | 287 | 124 | 7 | GO:0035770 | |
| GeneOntologyCellularComponent | lamellipodium | 2.52e-03 | 230 | 124 | 6 | GO:0030027 | |
| GeneOntologyCellularComponent | cuticular plate | 2.61e-03 | 13 | 124 | 2 | GO:0032437 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 2.61e-03 | 13 | 124 | 2 | GO:0002116 | |
| GeneOntologyCellularComponent | fascia adherens | 2.61e-03 | 13 | 124 | 2 | GO:0005916 | |
| MousePheno | abnormal telencephalon morphology | SLC12A6 PLXNA3 TRIO MAPT SPTA1 SPTAN1 SPTB APC2 ITGA5 CEP55 ITPR3 GMNC CELSR3 EIF4EBP2 TTC21B RORA WASF1 IMMT HTT PINK1 | 4.92e-07 | 812 | 96 | 20 | MP:0000787 |
| MousePheno | abnormal cerebral hemisphere morphology | SLC12A6 PLXNA3 TRIO MAPT SPTA1 SPTB APC2 ITGA5 CEP55 ITPR3 GMNC CELSR3 EIF4EBP2 WASF1 IMMT HTT PINK1 | 5.86e-07 | 599 | 96 | 17 | MP:0008540 |
| MousePheno | abnormal forebrain morphology | SLC12A6 PLXNA3 TRIO MAPT SPTA1 SPTAN1 SPTB APC2 PHF6 GXYLT1 ITGA5 CEP55 ITPR3 GMNC CELSR3 EIF4EBP2 TTC21B RORA WASF1 IMMT ALK HTT PINK1 | 6.68e-07 | 1072 | 96 | 23 | MP:0000783 |
| MousePheno | abnormal neuron physiology | RAG1 TRIO MAPT APC2 PHF6 ITGA5 CEP55 MET CELSR3 G3BP1 RORA CADPS2 WASF1 IMMT HTT PINK1 | 3.21e-06 | 604 | 96 | 16 | MP:0004811 |
| MousePheno | abnormal limbic system morphology | SLC12A6 PLXNA3 TRIO MAPT APC2 CEP55 GMNC EIF4EBP2 WASF1 IMMT ALK HTT | 1.04e-05 | 378 | 96 | 12 | MP:0004166 |
| MousePheno | cerebral infarct | 4.67e-05 | 2 | 96 | 2 | MP:0021003 | |
| MousePheno | paraparesis | 6.48e-05 | 32 | 96 | 4 | MP:0009434 | |
| MousePheno | abnormal cerebellum morphology | SLC12A6 APC2 CEP55 SLIT2 MET RORA CADPS2 CLEC16A IMMT GOLGA2 HTT | 7.12e-05 | 389 | 96 | 11 | MP:0000849 |
| MousePheno | abnormal hippocampus morphology | 8.98e-05 | 331 | 96 | 10 | MP:0000807 | |
| MousePheno | abnormal temporal lobe morphology | 1.04e-04 | 337 | 96 | 10 | MP:0000801 | |
| MousePheno | hindlimb paresis | 1.16e-04 | 37 | 96 | 4 | MP:0031204 | |
| MousePheno | abnormal extraembryonic mesoderm development | 1.35e-04 | 15 | 96 | 3 | MP:0006323 | |
| MousePheno | abnormal metencephalon morphology | SLC12A6 APC2 CEP55 SLIT2 MET RORA CADPS2 CLEC16A IMMT GOLGA2 HTT | 1.40e-04 | 420 | 96 | 11 | MP:0000847 |
| MousePheno | abnormal social/conspecific interaction behavior | MAPT SPTA1 PHF6 ITPR3 SIPA1L1 EIF4EBP2 LRP4 RORA CADPS2 HTT PINK1 | 1.43e-04 | 421 | 96 | 11 | MP:0002557 |
| MousePheno | anisopoikilocytosis | 1.99e-04 | 17 | 96 | 3 | MP:0002641 | |
| MousePheno | abnormal olfactory bulb morphology | 3.05e-04 | 133 | 96 | 6 | MP:0000819 | |
| MousePheno | abnormal cerebral cortex morphology | 4.17e-04 | 328 | 96 | 9 | MP:0000788 | |
| MousePheno | impaired coordination | SLC12A6 MAPT SYNE1 APC2 MET CELSR3 RORA CADPS2 WASF1 IMMT HTT | 4.27e-04 | 478 | 96 | 11 | MP:0001405 |
| MousePheno | abnormal myogenesis | 4.39e-04 | 52 | 96 | 4 | MP:0000729 | |
| MousePheno | abnormal olfactory bulb layer morphology | 4.40e-04 | 22 | 96 | 3 | MP:0009946 | |
| MousePheno | abnormal cardiac thrombosis | 4.40e-04 | 22 | 96 | 3 | MP:0020409 | |
| MousePheno | paresis | 4.73e-04 | 53 | 96 | 4 | MP:0000754 | |
| MousePheno | abnormal hindbrain morphology | SLC12A6 APC2 CEP55 SLIT2 MET RORA CADPS2 CLEC16A IMMT GOLGA2 HTT | 4.82e-04 | 485 | 96 | 11 | MP:0000841 |
| MousePheno | abnormal Purkinje cell morphology | 5.06e-04 | 204 | 96 | 7 | MP:0000877 | |
| Domain | Spectrin_repeat | 3.03e-08 | 29 | 123 | 6 | IPR002017 | |
| Domain | SPEC | 5.68e-08 | 32 | 123 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.68e-08 | 32 | 123 | 6 | IPR018159 | |
| Domain | Spectrin | 3.49e-07 | 23 | 123 | 5 | PF00435 | |
| Domain | LAM_G_DOMAIN | 1.11e-04 | 38 | 123 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 1.36e-04 | 40 | 123 | 4 | PF02210 | |
| Domain | LamG | 1.98e-04 | 44 | 123 | 4 | SM00282 | |
| Domain | - | PSD2 CDC42BPA TRIO ASAP3 OSBP RASAL3 TLN1 CADPS2 PHLPP2 ANKS1A | 2.65e-04 | 391 | 123 | 10 | 2.30.29.30 |
| Domain | PH_dom-like | PSD2 CDC42BPA TRIO ASAP3 OSBP RASAL3 TLN1 CADPS2 PHLPP2 ANKS1A | 5.20e-04 | 426 | 123 | 10 | IPR011993 |
| Domain | ASX_HYDROXYL | 5.22e-04 | 100 | 123 | 5 | PS00010 | |
| Domain | PH_DOMAIN | 5.25e-04 | 279 | 123 | 8 | PS50003 | |
| Domain | Laminin_G | 5.77e-04 | 58 | 123 | 4 | IPR001791 | |
| Domain | DUF4749 | 6.34e-04 | 6 | 123 | 2 | PF15936 | |
| Domain | EFhand_Ca_insen | 6.34e-04 | 6 | 123 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 6.34e-04 | 6 | 123 | 2 | IPR014837 | |
| Domain | DUF4749 | 6.34e-04 | 6 | 123 | 2 | IPR031847 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.81e-04 | 106 | 123 | 5 | IPR000152 | |
| Domain | IPT | 7.26e-04 | 27 | 123 | 3 | SM00429 | |
| Domain | Semap_dom | 1.09e-03 | 31 | 123 | 3 | IPR001627 | |
| Domain | SEMA | 1.09e-03 | 31 | 123 | 3 | PS51004 | |
| Domain | TIG | 1.09e-03 | 31 | 123 | 3 | PF01833 | |
| Domain | Sema | 1.09e-03 | 31 | 123 | 3 | SM00630 | |
| Domain | Sema | 1.09e-03 | 31 | 123 | 3 | PF01403 | |
| Domain | RecF/RecN/SMC_N | 1.17e-03 | 8 | 123 | 2 | IPR003395 | |
| Domain | SMC_N | 1.17e-03 | 8 | 123 | 2 | PF02463 | |
| Domain | IPT | 1.20e-03 | 32 | 123 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 1.20e-03 | 32 | 123 | 3 | IPR002165 | |
| Domain | PSI | 1.20e-03 | 32 | 123 | 3 | PF01437 | |
| Domain | EGF_CA | 1.28e-03 | 122 | 123 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.38e-03 | 124 | 123 | 5 | IPR001881 | |
| Domain | Plexin_cytopl | 1.50e-03 | 9 | 123 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.50e-03 | 9 | 123 | 2 | IPR013548 | |
| Domain | Plexin | 1.50e-03 | 9 | 123 | 2 | IPR031148 | |
| Domain | PI_Kinase | 1.87e-03 | 10 | 123 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 1.87e-03 | 10 | 123 | 2 | IPR001263 | |
| Domain | PIK_HELICAL | 1.87e-03 | 10 | 123 | 2 | PS51545 | |
| Domain | PH | 2.46e-03 | 278 | 123 | 7 | SM00233 | |
| Domain | PH_domain | 2.56e-03 | 280 | 123 | 7 | IPR001849 | |
| Domain | PSI | 3.03e-03 | 44 | 123 | 3 | IPR016201 | |
| Domain | Kinase-like_dom | 3.13e-03 | 542 | 123 | 10 | IPR011009 | |
| Domain | ConA-like_dom | 3.31e-03 | 219 | 123 | 6 | IPR013320 | |
| Domain | PSI | 3.44e-03 | 46 | 123 | 3 | SM00423 | |
| Domain | - | 3.59e-03 | 95 | 123 | 4 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 3.87e-03 | 97 | 123 | 4 | IPR018097 | |
| Domain | PH | 4.11e-03 | 229 | 123 | 6 | PF00169 | |
| Domain | EGF_CA | 4.17e-03 | 99 | 123 | 4 | PS01187 | |
| Domain | PI3/4_kinase_CS | 4.27e-03 | 15 | 123 | 2 | IPR018936 | |
| Domain | Spectrin_alpha_SH3 | 4.27e-03 | 15 | 123 | 2 | IPR013315 | |
| Domain | - | 4.86e-03 | 16 | 123 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.86e-03 | 16 | 123 | 2 | SM00146 | |
| Domain | - | 4.86e-03 | 16 | 123 | 2 | 1.10.506.10 | |
| Domain | PI3_PI4_kinase | 6.14e-03 | 18 | 123 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.14e-03 | 18 | 123 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.14e-03 | 18 | 123 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 6.14e-03 | 18 | 123 | 2 | IPR000403 | |
| Domain | RasGAP_dom | 6.14e-03 | 18 | 123 | 2 | IPR001936 | |
| Domain | PI3_4_KINASE_3 | 6.14e-03 | 18 | 123 | 2 | PS50290 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | PLXNA3 COL6A6 TRIO SPTA1 SPTAN1 SPTB ITGA5 SLIT2 MET TLN1 PLXNA1 | 8.11e-07 | 261 | 90 | 11 | MM15676 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | PLXNA3 COL6A6 TRIO SPTA1 SPTAN1 SPTB ITGA5 PPL KRT73 SLIT2 MET JUP TLN1 PLXNA1 | 3.32e-06 | 502 | 90 | 14 | MM14537 |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 2.06e-05 | 9 | 90 | 3 | MM15030 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.92e-05 | 10 | 90 | 3 | MM15112 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 8.71e-05 | 14 | 90 | 3 | M7578 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.71e-05 | 38 | 90 | 4 | MM14969 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 3.08e-04 | 21 | 90 | 3 | M8601 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 3.08e-04 | 21 | 90 | 3 | MM1463 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.09e-04 | 51 | 90 | 4 | MM14967 | |
| Pubmed | SLC12A6 CDC42BPA VPS26B ITGA5 ITPR3 PTPN1 JUP PI4KA EXD2 PI4KB IMMT PLXNA1 GOLGA2 DOP1B | 4.72e-09 | 504 | 126 | 14 | 34432599 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 3.39e-08 | 10 | 126 | 4 | 22159418 | |
| Pubmed | SPTAN1 SPTB PPL ITPR3 MET JUP SNCAIP PRRC2C TLN1 SF3B2 GOLGA2 | 8.83e-08 | 360 | 126 | 11 | 33111431 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 CDC42BPA TRIO MAPT SPTAN1 CCDC18 CCDC88C JUP CEP112 PRRC2C PI4KA PI4KB SIPA1L1 CRYBG3 DOP1B ANKS1A | 9.80e-08 | 861 | 126 | 16 | 36931259 |
| Pubmed | WAPL NUP210L SYNE1 SPTAN1 SMC6 MYO18A SMC4 RDH11 PI4KA MGA IMMT SF3B2 EP300 GOLGA2 ANKS1A | 1.06e-07 | 754 | 126 | 15 | 35906200 | |
| Pubmed | WAPL GNL3L OGT MAPT FAT3 SCEL PRDM5 SLIT2 FAT1 RASAL3 TNFSF13B SIPA1L1 LRP4 CRYBG3 LZTS2 MGA C1orf50 EP300 | 1.21e-07 | 1116 | 126 | 18 | 31753913 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GNL3L SPTAN1 MYO18A SMC4 PHF6 SRPK1 PPL CEP55 ITPR3 PTPN1 JUP MOGS G3BP1 PRRC2C SIPA1L1 LZTS2 IMMT SF3B2 GOLGA2 | 1.42e-07 | 1257 | 126 | 19 | 36526897 |
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 1.85e-07 | 4 | 126 | 3 | 3862089 | |
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 1.85e-07 | 4 | 126 | 3 | 12820899 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 21566095 | ||
| Pubmed | WAPL OGT TRIO SYNE1 SPTAN1 SPTB APC2 CELSR3 SIPA1L1 CCDC15 LRP4 GFPT2 CADPS2 IMMT SF3B2 EP300 SCAI PINK1 DOP1B | 1.99e-07 | 1285 | 126 | 19 | 35914814 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 4.83e-07 | 18 | 126 | 4 | 12119179 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 CDC42BPA TRIO ITGA5 ITPR3 CCNE1 CCDC88C FAT1 CELSR3 PLA2G4B PI4KA TLN1 LRP4 C1orf50 EP300 PLXNA1 HTT | 5.41e-07 | 1105 | 126 | 17 | 35748872 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.88e-07 | 202 | 126 | 8 | 33005030 | |
| Pubmed | WAPL OGT SPTAN1 SMC4 CEP55 JUP PRRC2C TLN1 LZTS2 MGA EP300 HTT | 8.10e-07 | 549 | 126 | 12 | 38280479 | |
| Pubmed | SLC12A6 OGT TRIO MAPT SYNE1 SPTA1 SPTAN1 SPTB MYO18A JUP G3BP1 PRRC2C PI4KA SIPA1L1 TLN1 GKAP1 WASF1 IMMT SCAI | 1.01e-06 | 1431 | 126 | 19 | 37142655 | |
| Pubmed | 1.61e-06 | 7 | 126 | 3 | 3186715 | ||
| Pubmed | USP53 CDC42BPA SYNE1 SPTAN1 MKNK2 MYO18A JUP RASAL3 MGA EP300 GOLGA2 | 1.70e-06 | 486 | 126 | 11 | 20936779 | |
| Pubmed | CDC42BPA SYNE1 SPTAN1 CCDC18 MYO18A SRPK1 CEP55 ITPR3 MET PTPN1 JUP MOGS PI4KA TLN1 GKAP1 CRYBG3 LZTS2 IMMT SF3B2 | 1.77e-06 | 1487 | 126 | 19 | 33957083 | |
| Pubmed | MEOX2 JUP CARD9 ASMTL EIF4EBP2 GKAP1 LZTS2 CADPS2 GOLGA2 HTT | 2.23e-06 | 402 | 126 | 10 | 24722188 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.66e-06 | 410 | 126 | 10 | 26949251 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | USP53 OGT ASAP3 PDLIM4 CEP55 MEOX2 JUP RDH11 CARD9 GKAP1 GFPT2 LZTS2 GOLGA2 | 3.20e-06 | 742 | 126 | 13 | 26871637 |
| Pubmed | Wapl repression by Pax5 promotes V gene recombination by Igh loop extrusion. | 3.84e-06 | 9 | 126 | 3 | 32612238 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | WAPL GNL3L TRIO SYNE1 SPTAN1 SMC6 SMC4 PHF6 PTPN1 JUP MOGS G3BP1 RDH11 PI4KA TLN1 IMMT SF3B2 PLXNA1 | 4.01e-06 | 1425 | 126 | 18 | 30948266 |
| Pubmed | 4.74e-06 | 118 | 126 | 6 | 30979931 | ||
| Pubmed | PSD2 SMC4 PHF6 SRPK1 OSBP MOGS G3BP1 RDH11 TLN1 GFPT2 SF3B2 EP300 | 4.82e-06 | 653 | 126 | 12 | 33742100 | |
| Pubmed | 5.72e-06 | 187 | 126 | 7 | 26460568 | ||
| Pubmed | 7.15e-06 | 272 | 126 | 8 | 31010829 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 SLC12A6 GNL3L OGT CDC42BPA TRIO MAPT SPTB HDAC8 PHF6 RDH11 ASMTL TTC21B LZTS2 CLEC16A EP300 HTT ANKS1A | 7.32e-06 | 1489 | 126 | 18 | 28611215 |
| Pubmed | A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells. | 7.50e-06 | 11 | 126 | 3 | 14625392 | |
| Pubmed | OGT TRIO SYNE1 SPTAN1 APC2 CCDC88C G3BP1 PRRC2C PI4KA SIPA1L1 MGA WASF1 GOLGA2 ANKS1A | 1.11e-05 | 963 | 126 | 14 | 28671696 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.14e-05 | 208 | 126 | 7 | 33230847 | |
| Pubmed | OGT CDC42BPA SPTAN1 SMC4 PHF6 SRPK1 ITPR3 JUP G3BP1 SIPA1L1 TLN1 LZTS2 MGA IMMT SF3B2 GOLGA2 | 1.19e-05 | 1247 | 126 | 16 | 27684187 | |
| Pubmed | Yeast two-hybrid screens implicate DISC1 in brain development and function. | 1.29e-05 | 13 | 126 | 3 | 14623284 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 28137874 | ||
| Pubmed | Epigenetic Mechanisms Underlying Organic Solute Transporter β Repression in Colorectal Cancer. | 1.30e-05 | 2 | 126 | 2 | 32005758 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19608626 | ||
| Pubmed | Deltex regulates T-cell activation by targeted degradation of active MEKK1. | 1.30e-05 | 2 | 126 | 2 | 15684388 | |
| Pubmed | Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease. | 1.30e-05 | 2 | 126 | 2 | 34233199 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18559482 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 9414314 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24193021 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 9005995 | ||
| Pubmed | Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis. | 1.30e-05 | 2 | 126 | 2 | 29440650 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24722154 | ||
| Pubmed | TLN1 synergizes with ITGA5 to ameliorate cardiac microvascular endothelial cell dysfunction. | 1.30e-05 | 2 | 126 | 2 | 37144848 | |
| Pubmed | Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease. | 1.30e-05 | 2 | 126 | 2 | 25205109 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 30477470 | ||
| Pubmed | αII-spectrin regulates invadosome stability and extracellular matrix degradation. | 1.30e-05 | 2 | 126 | 2 | 25830635 | |
| Pubmed | Expression and clinical relevance of MET and ALK in Ewing sarcomas. | 1.30e-05 | 2 | 126 | 2 | 23335077 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 2070088 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24527995 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 9373273 | ||
| Pubmed | Spectrin mutations in hereditary elliptocytosis and hereditary spherocytosis. | 1.30e-05 | 2 | 126 | 2 | 8844207 | |
| Pubmed | Type II phosphatidylinositol 4-kinases promote Listeria monocytogenes entry into target cells. | 1.30e-05 | 2 | 126 | 2 | 17555516 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 2346784 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 38030596 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 21327254 | ||
| Pubmed | Impact of Pre-Analytical Conditions on the Antigenicity of Lung Markers: ALK and MET. | 1.30e-05 | 2 | 126 | 2 | 30724750 | |
| Pubmed | Interaction between microtubule-associated protein tau and spectrin. | 1.30e-05 | 2 | 126 | 2 | 6743699 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 1634521 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 9890967 | ||
| Pubmed | Mutant huntingtin alters Tau phosphorylation and subcellular distribution. | 1.30e-05 | 2 | 126 | 2 | 25143394 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 27093462 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 21344240 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 32126881 | ||
| Pubmed | The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. | 1.30e-05 | 2 | 126 | 2 | 8910513 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 1391962 | ||
| Pubmed | Chaperone activity and prodan binding at the self-associating domain of erythroid spectrin. | 1.30e-05 | 2 | 126 | 2 | 15492010 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 8102379 | ||
| Pubmed | Aberrant role of ALK in tau proteinopathy through autophagosomal dysregulation. | 1.30e-05 | 2 | 126 | 2 | 33452442 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 7104494 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 6215583 | ||
| Pubmed | Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma. | 1.30e-05 | 2 | 126 | 2 | 27262592 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 31562564 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 3580577 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 7883966 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15634669 | ||
| Pubmed | Spectrin Cosenza: a novel beta chain variant associated with Sp alphaI/74 hereditary elliptocytosis. | 1.30e-05 | 2 | 126 | 2 | 9163587 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 8018926 | ||
| Pubmed | Erythrocyte spectrin is comprised of many homologous triple helical segments. | 1.30e-05 | 2 | 126 | 2 | 6472478 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23456457 | ||
| Pubmed | Improving mRNA 5' coding sequence determination in the mouse genome. | 1.30e-05 | 2 | 126 | 2 | 24504701 | |
| Pubmed | Expression of the c-Met proto-oncogene and Integrin α5β1 in human gastric cardia adenocarcinoma. | 1.30e-05 | 2 | 126 | 2 | 22976495 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 30198572 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 2056132 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19605471 | ||
| Pubmed | Parkinson's disease-associated PINK1 G309D mutation increases abnormal phosphorylation of Tau. | 1.30e-05 | 2 | 126 | 2 | 25899925 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 34434118 | ||
| Pubmed | B cell activating factor (BAFF) gene promoter activity depends upon co-activator, p300. | 1.30e-05 | 2 | 126 | 2 | 17869641 | |
| Pubmed | O-linked N-acetylglucosamine transferase (OGT) regulates pancreatic α-cell function in mice. | 1.30e-05 | 2 | 126 | 2 | 33460647 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 8226774 | ||
| Pubmed | Glycosylation of erythrocyte spectrin and its modification in visceral leishmaniasis. | 1.30e-05 | 2 | 126 | 2 | 22164239 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 20197550 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 29734651 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 17977835 | ||
| Pubmed | PLXNA3 GNL3L CDC42BPA APC2 SRPK1 KCNH4 CCNE1 PLA2G4B GFPT2 FUT4 EP300 PLXNA1 | 1.47e-05 | 730 | 126 | 12 | 34857952 | |
| Pubmed | CDC42BPA TRIO MAPT SPTAN1 MYO18A MET PTPN1 OSBP G3BP1 PRRC2C PI4KA SIPA1L1 CRYBG3 WASF1 CLEC16A | 1.69e-05 | 1139 | 126 | 15 | 36417873 | |
| Pubmed | TRIO SPTAN1 SMC4 PHF6 GXYLT1 SRPK1 RDH13 ITGA5 MET JUP FAT1 MOGS G3BP1 PRCP CEP112 PRRC2C | 1.93e-05 | 1297 | 126 | 16 | 33545068 | |
| Pubmed | ABCA4 PHF6 ITGA5 PRDM5 MEPE ITPR3 OSBP PI4KB GFPT2 WASF1 EP300 | 2.20e-05 | 638 | 126 | 11 | 31182584 | |
| Interaction | RHOB interactions | SLC12A6 GNL3L CDC42BPA TRIO SPTAN1 MYO18A ITGA5 CEP55 CCDC88C JUP FAT1 RDH11 PI4KA SIPA1L1 LRP4 LZTS2 WASF1 IMMT PLXNA1 | 1.03e-06 | 840 | 125 | 19 | int:RHOB |
| Interaction | YWHAH interactions | USP53 OGT CDC42BPA TRIO MAPT SPTAN1 CCDC18 CCDC88C JUP SNCAIP G3BP1 CEP112 PRRC2C PI4KA PI4KB SIPA1L1 CRYBG3 WASF1 CLEC16A HTT DOP1B ANKS1A | 1.06e-06 | 1102 | 125 | 22 | int:YWHAH |
| Interaction | RHOA interactions | CDC42BPA TRIO MAPT SPTAN1 MYO18A PHF6 RIPOR3 ITGA5 MAP3K1 CEP55 ITPR3 CCDC88C PTPN1 JUP FAT1 RDH11 PI4KA EXD2 CLEC16A IMMT PLXNA1 HTT PINK1 | 1.16e-06 | 1199 | 125 | 23 | int:RHOA |
| Interaction | ANK1 interactions | 1.27e-06 | 56 | 125 | 6 | int:ANK1 | |
| Interaction | DYRK1A interactions | OGT MAPT SPTAN1 PHF6 SRPK1 PPL MAP3K1 CEP55 SIPA1L1 CCDC15 LRP4 LZTS2 CLEC16A EP300 GOLGA2 | 1.72e-06 | 552 | 125 | 15 | int:DYRK1A |
| Interaction | YWHAG interactions | USP53 OGT CDC42BPA MAPT SPTAN1 CCDC18 SRPK1 MAP3K1 CEP55 CCDC88C JUP CEP112 PRRC2C PI4KA TNFSF13B PI4KB SIPA1L1 LZTS2 WASF1 PDE7B HTT PINK1 ANKS1A | 2.28e-06 | 1248 | 125 | 23 | int:YWHAG |
| Interaction | RAC1 interactions | CDC42BPA TRIO MAPT SPTAN1 MYO18A PHF6 ITGA5 CEP55 MET PTPN1 JUP FAT1 MOGS PI4KA LRP4 LZTS2 WASF1 IMMT PLXNA1 HTT ANKS1A | 2.29e-06 | 1063 | 125 | 21 | int:RAC1 |
| Interaction | RAB3D interactions | 5.31e-06 | 41 | 125 | 5 | int:RAB3D | |
| Interaction | SFN interactions | USP53 CDC42BPA MAPT SPTAN1 CCDC18 CCDC88C MET OSBP G3BP1 CEP112 PRRC2C PI4KB SIPA1L1 CRYBG3 HTT ANKS1A | 6.03e-06 | 692 | 125 | 16 | int:SFN |
| Interaction | LCK interactions | CDC42BPA TRIO MAPT SPTAN1 CEP55 MET JUP G3BP1 PI4KA CRYBG3 LZTS2 EP300 GOLGA2 | 6.22e-06 | 463 | 125 | 13 | int:LCK |
| Interaction | RAC3 interactions | CDC42BPA MAPT SPTAN1 MYO18A ITGA5 CEP55 PTPN1 JUP FAT1 PI4KA EXD2 WASF1 IMMT PLXNA1 ANKS1A | 6.91e-06 | 619 | 125 | 15 | int:RAC3 |
| Interaction | YWHAE interactions | OGT CDC42BPA MAPT SPTAN1 HDX CCDC18 MAP3K1 CEP55 CCDC88C JUP RASAL3 G3BP1 CEP112 PI4KB SIPA1L1 MGA WASF1 PDE7B SF3B2 HTT PINK1 ANKS1A | 8.83e-06 | 1256 | 125 | 22 | int:YWHAE |
| Interaction | CDC37 interactions | SLC12A6 OGT TRIO MAPT MAP3K1 CEP55 MET OSBP G3BP1 CARD9 MID1 IMMT ALK GOLGA2 PINK1 | 1.13e-05 | 645 | 125 | 15 | int:CDC37 |
| Interaction | KRT18 interactions | USP53 CDC42BPA CCDC18 KRT73 CEP55 ITPR3 G3BP1 CRYBG3 ALK SF3B2 EP300 GOLGA2 | 1.18e-05 | 419 | 125 | 12 | int:KRT18 |
| Interaction | SPSB4 interactions | 1.23e-05 | 124 | 125 | 7 | int:SPSB4 | |
| Interaction | SUSD4 interactions | 1.44e-05 | 50 | 125 | 5 | int:SUSD4 | |
| Interaction | CTNNB1 interactions | USP53 ABCA4 MAPT SPTAN1 APC2 CCNE1 CCDC88C SLIT2 MET PTPN1 OSBP JUP G3BP1 SIPA1L1 TLN1 LZTS2 IMMT EP300 HTT | 1.45e-05 | 1009 | 125 | 19 | int:CTNNB1 |
| Interaction | AHCY interactions | 1.47e-05 | 293 | 125 | 10 | int:AHCY | |
| Interaction | RAB11A interactions | CDC42BPA TRIO MAPT SPTAN1 ITPR3 PTPN1 JUP PI4KA EXD2 PI4KB LRP4 CRYBG3 LZTS2 CLEC16A GOLGA2 HTT DOP1B | 1.48e-05 | 830 | 125 | 17 | int:RAB11A |
| Interaction | YWHAZ interactions | OGT CDC42BPA COL6A6 MAPT SPTA1 SPTAN1 CCDC18 MYO18A MAP3K1 CCDC88C JUP RASAL3 CEP112 PI4KB SIPA1L1 WASF1 PDE7B SF3B2 EP300 HTT PINK1 ANKS1A | 1.89e-05 | 1319 | 125 | 22 | int:YWHAZ |
| Interaction | NUB1 interactions | 1.92e-05 | 53 | 125 | 5 | int:NUB1 | |
| Interaction | VCL interactions | 2.08e-05 | 305 | 125 | 10 | int:VCL | |
| Interaction | KCNA3 interactions | CDC42BPA MYO18A SMC4 PPL CEP55 CCDC88C PTPN1 JUP CEP112 PRRC2C SIPA1L1 TLN1 MID1 CRYBG3 IMMT SF3B2 ANKS1A | 2.73e-05 | 871 | 125 | 17 | int:KCNA3 |
| Interaction | CEP57L1 interactions | 2.79e-05 | 95 | 125 | 6 | int:CEP57L1 | |
| Interaction | GAN interactions | 2.90e-05 | 253 | 125 | 9 | int:GAN | |
| Interaction | RAB1B interactions | 2.90e-05 | 253 | 125 | 9 | int:RAB1B | |
| Interaction | TOP3B interactions | PLXNA3 CDC42BPA TRIO SPTAN1 SPTB ITGA5 ITPR3 CCNE1 CCDC88C FAT1 CELSR3 MOGS G3BP1 PLA2G4B PI4KA TLN1 GKAP1 LRP4 C1orf50 IMMT EP300 PLXNA1 HTT | 3.27e-05 | 1470 | 125 | 23 | int:TOP3B |
| Interaction | LRRC31 interactions | 4.25e-05 | 205 | 125 | 8 | int:LRRC31 | |
| Interaction | TRIM66 interactions | 4.25e-05 | 205 | 125 | 8 | int:TRIM66 | |
| Interaction | CEP135 interactions | CCDC18 SRPK1 CEP55 CCDC88C CARD9 CEP112 SIPA1L1 CCDC15 LZTS2 | 5.09e-05 | 272 | 125 | 9 | int:CEP135 |
| Interaction | FKBP5 interactions | USP53 OGT COL6A6 MAPT SPTAN1 MAP3K1 PRRC2C PI4KA SF3B2 PINK1 PHLPP2 | 5.48e-05 | 414 | 125 | 11 | int:FKBP5 |
| Interaction | ATG5 interactions | 5.76e-05 | 344 | 125 | 10 | int:ATG5 | |
| Interaction | RAB35 interactions | SLC12A6 CDC42BPA TRIO SPTAN1 ITGA5 PTPN1 JUP PI4KA EXD2 LZTS2 ALK PLXNA1 HTT | 5.78e-05 | 573 | 125 | 13 | int:RAB35 |
| Interaction | DTX1 interactions | 6.36e-05 | 35 | 125 | 4 | int:DTX1 | |
| Interaction | PIGH interactions | 6.60e-05 | 161 | 125 | 7 | int:PIGH | |
| Interaction | SORBS2 interactions | 6.72e-05 | 111 | 125 | 6 | int:SORBS2 | |
| Interaction | EXOSC5 interactions | 7.42e-05 | 164 | 125 | 7 | int:EXOSC5 | |
| Interaction | DEFA5 interactions | 7.43e-05 | 70 | 125 | 5 | int:DEFA5 | |
| Interaction | RAC2 interactions | CDC42BPA SPTAN1 MYO18A ITGA5 ITPR3 PTPN1 JUP FAT1 PI4KA EXD2 WASF1 IMMT PLXNA1 HTT | 7.65e-05 | 674 | 125 | 14 | int:RAC2 |
| Interaction | ANKRD12 interactions | 7.95e-05 | 37 | 125 | 4 | int:ANKRD12 | |
| Interaction | PTBP2 interactions | 8.50e-05 | 72 | 125 | 5 | int:PTBP2 | |
| Interaction | FAM184A interactions | 8.50e-05 | 72 | 125 | 5 | int:FAM184A | |
| Interaction | LATS1 interactions | OGT SPTAN1 CCDC18 KRT73 CEP55 CCDC88C JUP SIPA1L1 LZTS2 MGA GOLGA2 | 9.44e-05 | 440 | 125 | 11 | int:LATS1 |
| Interaction | ADD1 interactions | 9.64e-05 | 171 | 125 | 7 | int:ADD1 | |
| Interaction | SPTBN2 interactions | 1.00e-04 | 172 | 125 | 7 | int:SPTBN2 | |
| Interaction | ACTA1 interactions | 1.08e-04 | 371 | 125 | 10 | int:ACTA1 | |
| Interaction | GMNC interactions | 1.14e-04 | 3 | 125 | 2 | int:GMNC | |
| Interaction | RAB7A interactions | SLC12A6 CDC42BPA VPS26B MAPT ITGA5 ITPR3 PTPN1 JUP PI4KA EXD2 PI4KB CLEC16A IMMT PLXNA1 GOLGA2 DOP1B | 1.19e-04 | 886 | 125 | 16 | int:RAB7A |
| Interaction | TNIK interactions | 1.34e-04 | 381 | 125 | 10 | int:TNIK | |
| Interaction | PIN1 interactions | 1.39e-04 | 383 | 125 | 10 | int:PIN1 | |
| Interaction | C11orf52 interactions | 1.41e-04 | 311 | 125 | 9 | int:C11orf52 | |
| Interaction | PCDHGB5 interactions | 1.44e-04 | 43 | 125 | 4 | int:PCDHGB5 | |
| Interaction | FHL1 interactions | 1.54e-04 | 129 | 125 | 6 | int:FHL1 | |
| Interaction | RHOJ interactions | CDC42BPA SPTAN1 ITGA5 CEP55 MEOX2 MET JUP FAT1 RDH11 PI4KA IMMT PLXNA1 GOLGA2 | 1.56e-04 | 633 | 125 | 13 | int:RHOJ |
| Interaction | EIF3G interactions | 1.65e-04 | 249 | 125 | 8 | int:EIF3G | |
| Interaction | MYO19 interactions | 1.79e-04 | 252 | 125 | 8 | int:MYO19 | |
| Interaction | FLOT1 interactions | CDC42BPA TRIO SPTAN1 SRPK1 CEP55 PTPN1 JUP PI4KA CRYBG3 LZTS2 HTT | 1.84e-04 | 475 | 125 | 11 | int:FLOT1 |
| Interaction | SLC1A2 interactions | 1.88e-04 | 46 | 125 | 4 | int:SLC1A2 | |
| Interaction | MYO6 interactions | 1.90e-04 | 398 | 125 | 10 | int:MYO6 | |
| Interaction | FKBP6 interactions | 1.97e-04 | 86 | 125 | 5 | int:FKBP6 | |
| Interaction | SYNPO interactions | 1.98e-04 | 192 | 125 | 7 | int:SYNPO | |
| Interaction | SPTB interactions | 2.08e-04 | 87 | 125 | 5 | int:SPTB | |
| Interaction | DCANP1 interactions | 2.10e-04 | 19 | 125 | 3 | int:DCANP1 | |
| Interaction | DDX19A interactions | 2.20e-04 | 88 | 125 | 5 | int:DDX19A | |
| Interaction | SMC3 interactions | 2.32e-04 | 408 | 125 | 10 | int:SMC3 | |
| Interaction | RHOD interactions | CDC42BPA SPTAN1 SPTB MYO18A ITGA5 ITPR3 PTPN1 JUP PI4KA EXD2 IMMT PLXNA1 | 2.33e-04 | 572 | 125 | 12 | int:RHOD |
| Interaction | EPB41L4A interactions | 2.40e-04 | 140 | 125 | 6 | int:EPB41L4A | |
| Interaction | HOMER1 interactions | 2.40e-04 | 140 | 125 | 6 | int:HOMER1 | |
| Interaction | ZRANB2 interactions | 2.46e-04 | 199 | 125 | 7 | int:ZRANB2 | |
| Interaction | FBXO2 interactions | 2.46e-04 | 411 | 125 | 10 | int:FBXO2 | |
| Interaction | PPP1R18 interactions | 2.50e-04 | 141 | 125 | 6 | int:PPP1R18 | |
| Interaction | DYRK1B interactions | 2.57e-04 | 91 | 125 | 5 | int:DYRK1B | |
| Interaction | NSMCE4A interactions | 2.61e-04 | 50 | 125 | 4 | int:NSMCE4A | |
| Interaction | PRKAR2B interactions | 2.70e-04 | 143 | 125 | 6 | int:PRKAR2B | |
| Interaction | RHOC interactions | RIPOR3 ITGA5 MET PTPN1 JUP FAT1 PI4KA EXD2 CLEC16A IMMT PLXNA1 HTT | 2.81e-04 | 584 | 125 | 12 | int:RHOC |
| Interaction | LGALS9 interactions | SLC12A6 SPTAN1 SMC4 SRPK1 ITGA5 MET JUP G3BP1 TLN1 IMMT PLXNA1 GOLGA2 | 2.99e-04 | 588 | 125 | 12 | int:LGALS9 |
| Interaction | GSK3B interactions | OGT TRIO MAPT MKNK2 MAP3K1 CCNE1 MET PTPN1 SNCAIP MOGS PRRC2C SIPA1L1 CRYBG3 LZTS2 ANKS1A | 3.16e-04 | 868 | 125 | 15 | int:GSK3B |
| Interaction | CTNNA1 interactions | 3.18e-04 | 347 | 125 | 9 | int:CTNNA1 | |
| Interaction | DTX4 interactions | 3.29e-04 | 22 | 125 | 3 | int:DTX4 | |
| Interaction | FAM167A interactions | 3.30e-04 | 96 | 125 | 5 | int:FAM167A | |
| Interaction | CDK9 interactions | OGT CDC42BPA SPTAN1 SPTB MYO18A SMC4 CCNE1 PRRC2C SIPA1L1 IMMT ALK SF3B2 EP300 | 3.36e-04 | 685 | 125 | 13 | int:CDK9 |
| Interaction | RHOU interactions | SLC12A6 CDC42BPA SPTAN1 MYO18A ITGA5 MET JUP PDLIM3 PI4KA IMMT PLXNA1 | 3.38e-04 | 510 | 125 | 11 | int:RHOU |
| Interaction | RHOH interactions | SLC12A6 CDC42BPA SPTAN1 MYO18A ITGA5 CEP55 MET PTPN1 JUP PI4KA IMMT | 3.50e-04 | 512 | 125 | 11 | int:RHOH |
| Interaction | KCTD13 interactions | SLC12A6 OGT TRIO MAPT SYNE1 SPTA1 SPTAN1 SPTB MYO18A JUP G3BP1 PRRC2C PI4KA SIPA1L1 TLN1 GKAP1 GFPT2 WASF1 IMMT SCAI | 3.61e-04 | 1394 | 125 | 20 | int:KCTD13 |
| Interaction | SMC4 interactions | 3.72e-04 | 281 | 125 | 8 | int:SMC4 | |
| Interaction | TAFA4 interactions | 3.77e-04 | 55 | 125 | 4 | int:TAFA4 | |
| Interaction | RBPJL interactions | 3.77e-04 | 23 | 125 | 3 | int:RBPJL | |
| Interaction | CPNE6 interactions | 3.77e-04 | 23 | 125 | 3 | int:CPNE6 | |
| Interaction | SLC6A11 interactions | 3.77e-04 | 5 | 125 | 2 | int:SLC6A11 | |
| Interaction | PRKACA interactions | MAPT HDAC8 ITPR3 EXD2 EIF4EBP2 GFPT2 CRYBG3 WASF1 IMMT HTT PINK1 | 3.92e-04 | 519 | 125 | 11 | int:PRKACA |
| Interaction | KAT5 interactions | 3.99e-04 | 358 | 125 | 9 | int:KAT5 | |
| Interaction | LMO1 interactions | 4.01e-04 | 154 | 125 | 6 | int:LMO1 | |
| Interaction | PRKAR2A interactions | 4.15e-04 | 217 | 125 | 7 | int:PRKAR2A | |
| Interaction | KRT8 interactions | 4.30e-04 | 441 | 125 | 10 | int:KRT8 | |
| Interaction | RAB5A interactions | SLC12A6 MAPT SPTAN1 CCDC88C PTPN1 JUP SLC9A3 MOGS RDH11 EXD2 PI4KB HTT DOP1B | 4.47e-04 | 706 | 125 | 13 | int:RAB5A |
| Interaction | SYNE3 interactions | CCDC18 GXYLT1 CEP55 ITPR3 PTPN1 MOGS SIPA1L1 CCDC15 CRYBG3 LZTS2 | 4.53e-04 | 444 | 125 | 10 | int:SYNE3 |
| Interaction | WDR5 interactions | OGT SPTAN1 MYO18A CEP55 ITPR3 MEOX2 PTPN1 JUP MOGS G3BP1 PRRC2C TLN1 MGA IMMT SF3B2 EP300 GOLGA2 | 4.58e-04 | 1101 | 125 | 17 | int:WDR5 |
| Interaction | SRSF2 interactions | 4.59e-04 | 290 | 125 | 8 | int:SRSF2 | |
| Interaction | ODF2 interactions | 4.60e-04 | 158 | 125 | 6 | int:ODF2 | |
| Interaction | PFN2 interactions | 4.75e-04 | 159 | 125 | 6 | int:PFN2 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.85e-06 | 7 | 88 | 3 | 1113 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 4.84e-04 | 7 | 88 | 2 | 761 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.07e-04 | 206 | 88 | 6 | 682 | |
| GeneFamily | Plexins | 8.25e-04 | 9 | 88 | 2 | 683 | |
| GeneFamily | LIM domain containing | 2.98e-03 | 59 | 88 | 3 | 1218 | |
| GeneFamily | Cadherin related | 3.04e-03 | 17 | 88 | 2 | 24 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL | SETD9 ABCA4 DTX1 SYNE1 MAP3K1 PDLIM4 MET OSBP PDLIM3 ASGR1 MID1 HAPLN3 PDE7B | 6.95e-08 | 402 | 125 | 13 | M45754 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | USP53 MKNK2 ASAP3 PPL PDLIM4 ITPR3 BNC1 MET JUP SNCAIP MOGS MID1 GKAP1 GFPT2 CADPS2 WASF1 PDE7B SCAI PHLPP2 | 1.38e-07 | 955 | 125 | 19 | M45680 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | SETD9 ABCA4 DTX1 SYNE1 SRPK1 PPL PDLIM4 MET RASAL3 PDLIM3 ASGR1 MID1 PDE7B DOP1B | 1.20e-06 | 604 | 125 | 14 | M45760 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | SPTAN1 MKNK2 MYO18A ITGA5 KRT73 INIP ITPR3 RASAL3 MOGS CARD9 PLA2G4B PI4KA FUT4 CLEC16A EP300 DOP1B ANKS1A | 1.47e-06 | 905 | 125 | 17 | M40865 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | WAPL OGT CDC42BPA TRIO SLIT2 PTPN1 FAT1 PRRC2C SIPA1L1 MID1 CRYBG3 WASF1 CLEC16A PHLPP2 DOP1B ANKS1A | 3.28e-06 | 856 | 125 | 16 | M4500 |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP | 5.48e-06 | 200 | 125 | 8 | M6398 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 5.48e-06 | 200 | 125 | 8 | M9133 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | WAPL OGT CDC42BPA TRIO FAT1 PRRC2C MID1 CLEC16A PHLPP2 DOP1B ANKS1A | 1.50e-05 | 466 | 125 | 11 | M13522 |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN | 5.06e-05 | 200 | 125 | 7 | M5204 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP | 5.06e-05 | 200 | 125 | 7 | M8569 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 5.06e-05 | 200 | 125 | 7 | M9952 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 5.82e-05 | 86 | 125 | 5 | M39248 | |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | 9.34e-05 | 382 | 125 | 9 | M38972 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL | SETD9 GXYLT1 MAP3K1 PDLIM4 BNC1 JUP SNCAIP MID1 GKAP1 CADPS2 WASF1 | 1.15e-04 | 584 | 125 | 11 | M45668 |
| Coexpression | NUMATA_CSF3_SIGNALING_VIA_STAT3 | 1.32e-04 | 21 | 125 | 3 | MM633 | |
| Coexpression | NUMATA_CSF3_SIGNALING_VIA_STAT3 | 1.32e-04 | 21 | 125 | 3 | M1454 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | MKNK2 SCEL PPL PDLIM4 ITPR3 BNC1 MET GKAP1 GFPT2 CADPS2 CLEC16A PHLPP2 | 1.42e-04 | 704 | 125 | 12 | M45672 |
| Coexpression | GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN | 1.48e-04 | 166 | 125 | 6 | M8182 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | USP53 TRIO FAT3 SMC4 PRDM5 BNC1 SLIT2 PRRC2C TLN1 MID1 EIF4EBP2 MGA IMMT HTT SCAI | 5.84e-05 | 790 | 124 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#5_top-relative-expression-ranked_200 | 5.99e-05 | 71 | 124 | 5 | gudmap_developingKidney_e12.5_renal vesicle_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.28e-05 | 230 | 124 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.16e-08 | 190 | 126 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-08 | 194 | 126 | 8 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-08 | 194 | 126 | 8 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.10e-08 | 196 | 126 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.10e-08 | 196 | 126 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.84e-08 | 198 | 126 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.25e-07 | 180 | 126 | 7 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.07e-06 | 187 | 126 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-06 | 191 | 126 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-06 | 192 | 126 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.27e-06 | 192 | 126 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 193 | 126 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 193 | 126 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-06 | 194 | 126 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.41e-06 | 195 | 126 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-06 | 195 | 126 | 7 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.56e-06 | 198 | 126 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.61e-06 | 199 | 126 | 7 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.61e-06 | 199 | 126 | 7 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.61e-06 | 199 | 126 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.61e-06 | 199 | 126 | 7 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-06 | 200 | 126 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.93e-06 | 158 | 126 | 6 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 166 | 126 | 6 | 5c132f505dc5f699c87913f140344fc9f8e7e0f5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.87e-06 | 166 | 126 | 6 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.87e-06 | 166 | 126 | 6 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.87e-06 | 166 | 126 | 6 | 941d6aa94ab9d36e5f6c40f446c926754e070d56 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.87e-06 | 166 | 126 | 6 | 6f5ecf3b2cf613ae0535ab3d21d93622f1497571 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 174 | 126 | 6 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 174 | 126 | 6 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-05 | 178 | 126 | 6 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-05 | 178 | 126 | 6 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 178 | 126 | 6 | 79823d13652177de852c2acce9159049241f1d86 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 178 | 126 | 6 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-05 | 178 | 126 | 6 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-05 | 183 | 126 | 6 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.65e-05 | 189 | 126 | 6 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-05 | 189 | 126 | 6 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 189 | 126 | 6 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 189 | 126 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 189 | 126 | 6 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 191 | 126 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 192 | 126 | 6 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 192 | 126 | 6 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 193 | 126 | 6 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.85e-05 | 193 | 126 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.85e-05 | 193 | 126 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 193 | 126 | 6 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 193 | 126 | 6 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-05 | 194 | 126 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-05 | 194 | 126 | 6 | c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 195 | 126 | 6 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.96e-05 | 195 | 126 | 6 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.96e-05 | 195 | 126 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.96e-05 | 195 | 126 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 195 | 126 | 6 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.96e-05 | 195 | 126 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 126 | 6 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 126 | 6 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-05 | 196 | 126 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.02e-05 | 196 | 126 | 6 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 126 | 6 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-05 | 196 | 126 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 126 | 6 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | distal-Endothelial-Lymphatic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.02e-05 | 196 | 126 | 6 | b0f23dc802a2c2a56a08d398a464ea78b58ade4c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-05 | 197 | 126 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.08e-05 | 197 | 126 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-05 | 197 | 126 | 6 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.08e-05 | 197 | 126 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.14e-05 | 198 | 126 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-05 | 198 | 126 | 6 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | medial-Endothelial-Lymphatic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-05 | 198 | 126 | 6 | 41983d405215b974044e2e9e6c212b134336a6fe | |
| ToppCell | medial-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-05 | 198 | 126 | 6 | e4274584512a72270087a1ab104fab449a2f83bc | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-05 | 198 | 126 | 6 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.14e-05 | 198 | 126 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.14e-05 | 198 | 126 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | medial-Endothelial-Lymphatic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-05 | 198 | 126 | 6 | 1760fede363544bc0fa2e22fe36aff522abd2525 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 199 | 126 | 6 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.20e-05 | 199 | 126 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-05 | 200 | 126 | 6 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.26e-05 | 200 | 126 | 6 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.26e-05 | 200 | 126 | 6 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.26e-05 | 200 | 126 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.26e-05 | 200 | 126 | 6 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.26e-05 | 200 | 126 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.26e-05 | 200 | 126 | 6 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-05 | 200 | 126 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.90e-05 | 140 | 126 | 5 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.60e-05 | 144 | 126 | 5 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type | 7.47e-05 | 153 | 126 | 5 | b24c693b142206d13b29c96faa7f79a1a22bc2ef | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-05 | 158 | 126 | 5 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-05 | 158 | 126 | 5 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-05 | 158 | 126 | 5 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| Drug | plakin | 3.62e-07 | 82 | 126 | 7 | CID000018752 | |
| Disease | neuroimaging measurement | CDC42BPA MAPT FAT3 MAP3K1 GMNC CCDC88C SLIT2 PTPN1 G3BP1 CEP112 PRRC2C RORA HTT SCAI ANKS1A | 3.30e-05 | 1069 | 121 | 15 | EFO_0004346 |
| Disease | cortical thickness | ABCA4 MAPT NUP210L FAT3 PRDM5 MAP3K1 GMNC BNC1 SLIT2 G3BP1 CEP112 PI4KA LRP4 RORA ANKS1A | 5.22e-05 | 1113 | 121 | 15 | EFO_0004840 |
| Disease | Parkinson disease | 9.78e-05 | 22 | 121 | 3 | cv:C0030567 | |
| Disease | Hereditary elliptocytosis | 9.95e-05 | 4 | 121 | 2 | cv:C0013902 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 1.65e-04 | 5 | 121 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 1.65e-04 | 5 | 121 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 1.65e-04 | 5 | 121 | 2 | C0221409 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.84e-04 | 286 | 121 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | Elliptocytosis, Hereditary | 2.47e-04 | 6 | 121 | 2 | C0013902 | |
| Disease | platelet component distribution width | MYO1G NUP210L SYNE1 SPTA1 RIPOR3 RDH13 G3BP1 PRRC2C TNFSF13B TLN1 ANKS1A | 2.85e-04 | 755 | 121 | 11 | EFO_0007984 |
| Disease | uridine measurement | 3.06e-04 | 32 | 121 | 3 | EFO_0010546 | |
| Disease | hippocampal CA3 volume | 4.35e-04 | 36 | 121 | 3 | EFO_0009395 | |
| Disease | Hereditary spherocytosis | 4.59e-04 | 8 | 121 | 2 | C0037889 | |
| Disease | Cognition Disorders | 5.11e-04 | 38 | 121 | 3 | C0009241 | |
| Disease | Colorectal Carcinoma | 6.45e-04 | 702 | 121 | 10 | C0009402 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Parkinson disease, late-onset | 7.35e-04 | 10 | 121 | 2 | cv:C3160718 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 7.35e-04 | 10 | 121 | 2 | 168600 | |
| Disease | kidney cancer | 8.95e-04 | 11 | 121 | 2 | MONDO_0002367 | |
| Disease | Neuroblastoma | 9.56e-04 | 47 | 121 | 3 | C0027819 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 1.07e-03 | 12 | 121 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 1.07e-03 | 12 | 121 | 2 | C3160718 | |
| Disease | bone density | 1.13e-03 | 388 | 121 | 7 | EFO_0003923 | |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 1.26e-03 | 13 | 121 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | Drug habituation | 1.31e-03 | 115 | 121 | 4 | C0013170 | |
| Disease | Drug abuse | 1.31e-03 | 115 | 121 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.31e-03 | 115 | 121 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.31e-03 | 115 | 121 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.31e-03 | 115 | 121 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.31e-03 | 115 | 121 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.31e-03 | 115 | 121 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.31e-03 | 115 | 121 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.31e-03 | 115 | 121 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.35e-03 | 116 | 121 | 4 | C0740858 | |
| Disease | sulfate measurement | 1.47e-03 | 14 | 121 | 2 | EFO_0007864 | |
| Disease | Malignant neoplasm of breast | ABCA4 ZNF366 SYNE1 SPTAN1 APC2 SMC6 MAP3K1 CCNE1 SIPA1L1 LZTS2 ALK EP300 | 1.56e-03 | 1074 | 121 | 12 | C0006142 |
| Disease | T-Cell Lymphoma | 1.93e-03 | 16 | 121 | 2 | C0079772 | |
| Disease | brain measurement, neuroimaging measurement | 1.98e-03 | 550 | 121 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | hypertension, white matter hyperintensity measurement | 2.13e-03 | 62 | 121 | 3 | EFO_0000537, EFO_0005665 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 2.72e-03 | 19 | 121 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.61e-03 | 152 | 121 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Parkinson's disease (is_implicated_in) | 3.80e-03 | 76 | 121 | 3 | DOID:14330 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEQHEATKVLQDAIH | 631 | Q7Z4L5 | |
| ALAELRENHGQADHS | 256 | Q6ZT62 | |
| LDNEESDHHQLRKGP | 11 | P07306 | |
| NEAAALNLEHLHEVA | 906 | Q5RHP9 | |
| LHAHKCQRREQANGE | 346 | Q09472 | |
| HHKECEELLEQAQAG | 666 | Q8TDY4 | |
| LQNPSDHHEDGIKRE | 156 | Q68DQ2 | |
| LEDTGLHHKRNEEAQ | 1046 | P78363 | |
| KELEHVGQHALARQI | 701 | Q01954 | |
| LKHFRGVADEDAHNI | 346 | P24864 | |
| LDFENEKLDRQHVQH | 361 | Q53EZ4 | |
| LQQHNAEKDSLVRDH | 676 | Q8N8E3 | |
| EQDHVEHNLAAERRK | 131 | Q8WYK0 | |
| LNNHDRKHAVGDDAQ | 101 | Q13542 | |
| AHEHNQEVVLKDGRI | 241 | Q5VSY0 | |
| HAALNGHKDVVEVLL | 86 | Q92625 | |
| ELHAQHARGLQEKDA | 366 | Q9H257 | |
| FHDNEKARGKAIHQA | 91 | P15918 | |
| NEGHSLKNLEHRLNE | 956 | Q86YV0 | |
| NEHHEKSVRQLAQEA | 701 | Q14573 | |
| KDALKRHQENVHTGD | 276 | Q9NQX1 | |
| ELQHEHSLKIEARDQ | 886 | Q14517 | |
| RQNDILHHGALDVGE | 401 | Q9UBM8 | |
| PFDHSRIKLHQEDND | 51 | P18031 | |
| PNDARAHKEEDHHAV | 561 | Q7Z353 | |
| DVEDAREQRAHNAHL | 106 | Q9BRK4 | |
| QGRVHLRQDKEHDVS | 116 | Q96S86 | |
| ELQLAAGRHGDDLKH | 331 | Q86Y46 | |
| RQEEKNKDNIGFHHL | 36 | Q9NQ76 | |
| QLKRHNKVDNPEADH | 426 | Q8IWI9 | |
| EAQAVLFHHRDLVKG | 231 | P22083 | |
| QHHRALGKKAEDLFQ | 401 | O95671 | |
| LEHHLGRAHEEAENQ | 1451 | Q9Y3R5 | |
| RLKGNLEEENHHLLS | 1326 | Q9P219 | |
| VDHNHQKLLRKFGED | 601 | Q9NVH0 | |
| LVKNHDHLDQREGDR | 1656 | Q9UIW2 | |
| LVKNHDHADHREGDR | 1631 | P51805 | |
| DHLVQQGIAHRDLKS | 351 | Q9BXM7 | |
| SALDFLHNKGIAHRD | 191 | Q9HBH9 | |
| DTKLHLEGQQVRNHE | 1441 | Q92614 | |
| NKLHSEGDQLLAAEH | 271 | O60437 | |
| AHLHNKDLRLEDAQD | 296 | Q9NP56 | |
| AEDQLHHSFKGRLDN | 151 | Q4G148 | |
| SEGAHHLDLRTKNAL | 451 | P42785 | |
| QGELQKILHDADRIH | 411 | P42356 | |
| QRLHKALEGHQEHRA | 81 | Q9UQ05 | |
| KALEHHRSEIQAEQD | 451 | Q16891 | |
| EDEQKASHQHQEALR | 96 | A8MZA4 | |
| NNIAKRHDEFERHAE | 86 | P01275 | |
| KEQIRELEAEFAHHN | 196 | P50222 | |
| DHKLSDQREALSHGQ | 416 | P0C869 | |
| ALAHTQHAARQKEGE | 236 | Q08379 | |
| LAKQHNHLERAFRGA | 311 | P22059 | |
| LVKAHQDAQRHVAAG | 531 | P14923 | |
| HHIENVLKEDARGSV | 46 | Q86Y01 | |
| EAAAKDIRGETLNHH | 76 | Q8NBN7 | |
| HQARAAKLHGELRAN | 776 | Q13724 | |
| ELDPEGSLHHQQKRE | 881 | P08648 | |
| DARHLAQALEHLEKQ | 731 | O95996 | |
| SFLEAKAENLHRGAH | 881 | P42858 | |
| HNLQTLEEENKHLAD | 511 | Q8NCX0 | |
| AIDGNNHEVKERHIQ | 41 | O94808 | |
| SLRHKVNEHEQDGNE | 61 | Q96C57 | |
| QLSKEKDAHGNHLAE | 1176 | Q5T9S5 | |
| KIRHVDAHATLNDGV | 76 | Q13283 | |
| AERLDHEAQDKHILN | 1521 | Q8TDW7 | |
| LQQNEEHHAEGREAF | 851 | Q86UW7 | |
| LQHLQKVSQEGDDDH | 76 | Q9BY41 | |
| IHIQAVDADHGENAR | 671 | Q9NYQ7 | |
| HSQLLDDGHKKARNA | 101 | Q9UHW9 | |
| QHLQEQARKVLEDAH | 86 | Q9BV19 | |
| RHVHESVKQLNGDAF | 2046 | A6NMZ7 | |
| LQDHRVALNGSHSEK | 296 | Q5VU65 | |
| NGKAADRIHQDGIHI | 621 | O15294 | |
| EVLHLDEAKDHNSLN | 76 | Q86UW2 | |
| HENQIIHRDVKGANL | 1361 | Q13233 | |
| KHGDLRNFIRNETHN | 1161 | P08581 | |
| AEEKHLHVLINNAGV | 116 | Q8TC12 | |
| TDHLADRQANHKDQL | 346 | Q96M34 | |
| AEEEHHLEKQRSGLQ | 141 | Q17RD7 | |
| DLLQNTDAHKRAFHE | 451 | Q8NF91 | |
| QKEEELARLHEENNH | 96 | A6NCL1 | |
| FVHPNDHANREAELK | 46 | Q9NVN8 | |
| APDDSKAQAHRIHID | 91 | P50479 | |
| NEKLHGRAFDHILSA | 476 | P48764 | |
| HNQLEAHPKADFIRE | 851 | Q9Y520 | |
| DKAHLQAEVQHLRED | 1761 | O43166 | |
| AVEHQGVKLLENRHQ | 91 | Q8NE22 | |
| HLAADNLDKIHDENG | 336 | Q9Y6H5 | |
| THADAQDRIKAAAHQ | 61 | Q53GG5 | |
| NETLRHKEDLHNAND | 371 | Q96SB4 | |
| DRHNGNILLDAEGHI | 671 | Q9UBF8 | |
| EHRLGQNGIEDFKKH | 326 | Q5VT25 | |
| LNKDFRDHAEQQHIA | 51 | Q9NRY2 | |
| HIRKLHASGQLDDAI | 46 | A0A1B0GWK0 | |
| LKDARFQDHQDHALL | 506 | Q9UM73 | |
| DQDFLPRDQHVLHKD | 446 | Q0P6D6 | |
| NRGKLSDLVAEHLDH | 246 | Q2KHT3 | |
| NAREHIHQSDEQKLE | 806 | Q70EK8 | |
| GNHHEFVSLVKDLAR | 81 | Q4G0F5 | |
| EERAKQQGDHSLKEH | 161 | Q13435 | |
| QQGDHSLKEHELLEQ | 166 | Q13435 | |
| HVGEEENEARGKLHI | 216 | Q8IWS0 | |
| GDNALRHDNDLLHHQ | 111 | P51786 | |
| EGNKHITHVDLRDNR | 436 | Q6ZVD8 | |
| VQQAELDHLSGRHKD | 91 | Q96MK2 | |
| ERSHFHNIKAQGEAA | 141 | Q96MW7 | |
| LALQHVLQKNHREDG | 451 | P35398 | |
| EGDLKNAIRVHHALA | 566 | Q9BQI7 | |
| RHHDNAKTEALQEEL | 691 | Q5TF21 | |
| AAENEEIGSHIKHRV | 1906 | Q9Y490 | |
| HNSHDALDRKVNERD | 66 | O95171 | |
| KHQAFEAELHANADR | 1591 | Q13813 | |
| AEHSLKENDHARFLQ | 316 | O15344 | |
| EELDLNKALQHAGKH | 1101 | Q7Z5K2 | |
| LKLEQIDGHIAEHNS | 1016 | Q9NTJ3 | |
| DIINGDAIHKRNQSH | 396 | Q8N9R8 | |
| QKIQAEHASHGDREE | 876 | Q96SB8 | |
| VQKEQAHSEEHLGRA | 311 | P10636 | |
| HLRGHNVAEVQKREF | 241 | O94813 | |
| QQHAGIKDEIDGHQD | 1101 | P11277 | |
| DVAGGEVLLDRHQQH | 401 | P02549 | |
| ELKAHEAKHASGREN | 351 | Q8N895 | |
| DDANLLHKHIEVANG | 216 | Q92558 | |
| LASLRAELQGHHAEK | 76 | Q9Y275 | |
| VCNRGHHDDDLKEFN | 256 | Q9NX94 | |
| HEKQQELDLAAEQHR | 886 | O75962 | |
| ELDLAAEQHRKHLEQ | 891 | O75962 | |
| DAKHHVIERANLDGS | 616 | O75096 | |
| QLLRGSEDKQLHELH | 206 | B0I1T2 | |
| HLSVDNEHRGQGIAK | 141 | Q9UHF3 |